Betamox injection

Betamox Injection is an antimicrobial suspension for injection containing 150 mg/ml of amoxicillin. Indicated for the treatment of infections caused by a wide range of Gram-positive and Gram-negative pathogenic bacteria in cattle, sheep, pigs, dogs and cats.

Target Species: Beef cattle, dairy cattle, sheep and pigs

Summary of Product Characteristics Technical Enquiry

Active Ingredient

Each ml contains: Amoxicillin 150 mg (as Amoxicillin Trihydrate 172.1 mg)
Pharmaceutical Form
Indications

For the treatment of infections caused by a wide range of Gram-positive and Gram-negative pathogenic bacteria including: Actinobacillus equuli, Actinomyces bovis, Actinobacillus lignieresi, Bacillus anthracis, Erysipelothrix rhusiopathiae, Bordetella bronchiseptica, Escherichia coli, Clostridium species, Haemophilus species, Corynebacterium species, Pasteurella species, Fusiformis species, Proteus mirabilis, Moraxella species, Salmonella species, Staphylococci, Streptococci. Not effective against beta-lactamase producing organisms.
Dosage

Cattle, sheep and pigs : By intramuscular injection only. Dogs and cats : By subcutaneous or intramuscular injection. The recommended dosage rate is 7 mg/kg bodyweight once a day for up to five days. Massage the injection site. A separate injection site should be used for each administration. Cattle (450 kg) 20.0ml, Sheep (65 kg) 3.0ml, Pigs (150 kg) 7.0ml, Dogs (20 kg) 1.0ml, Cats (5 kg) 0.25ml (Guide-dose volume is equivalent to about 0.25 ml per 5 kg daily). Normal aseptic precautions should be observed. Shake vial before use. This product does not contain an antimicrobial preservative. Swab the septum before removing each dose. Use a dry, sterile needle and syringe. If dose volume exceeds 20 ml in cattle or 10 ml in pigs, it should be divided and injected into two sites.

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.

Prefer to speak directly to a member of our team?

Norbrook MENA

+44 (0)28 3026 4435 enquiries@norbrook.co.uk

All enquiries for the MENA team are manged by the Norbrook Head Office in Northern Ireland

We are open Mon - Fri 9:00am - 5:00pm